Hepatitis B Surface Antigens
"Hepatitis B Surface Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen.
| Descriptor ID |
D006514
|
| MeSH Number(s) |
D23.050.327.495.500.475
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis B Surface Antigens".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B Surface Antigens".
This graph shows the total number of publications written about "Hepatitis B Surface Antigens" by people in this website by year, and whether "Hepatitis B Surface Antigens" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 1 | 4 |
| 1996 | 3 | 0 | 3 |
| 1997 | 1 | 4 | 5 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 2 | 3 | 5 |
| 2002 | 3 | 3 | 6 |
| 2003 | 2 | 2 | 4 |
| 2004 | 2 | 5 | 7 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 3 | 4 |
| 2008 | 4 | 6 | 10 |
| 2009 | 2 | 5 | 7 |
| 2010 | 0 | 3 | 3 |
| 2011 | 2 | 3 | 5 |
| 2012 | 0 | 5 | 5 |
| 2013 | 1 | 4 | 5 |
| 2014 | 2 | 4 | 6 |
| 2015 | 0 | 6 | 6 |
| 2016 | 2 | 5 | 7 |
| 2017 | 2 | 2 | 4 |
| 2018 | 3 | 7 | 10 |
| 2019 | 7 | 5 | 12 |
| 2020 | 2 | 6 | 8 |
| 2021 | 0 | 15 | 15 |
| 2022 | 1 | 11 | 12 |
| 2023 | 2 | 12 | 14 |
| 2024 | 1 | 5 | 6 |
Below are the most recent publications written about "Hepatitis B Surface Antigens" by people in Profiles.
-
Community-Based Point-of-Care Screening for Hepatitis B Virus and Hepatocellular Carcinoma in Rural Tanzania. Am J Trop Med Hyg. 2025 Jan 08; 112(1):167-172.
-
Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey. Liver Transpl. 2024 Nov 01; 30(11):1116-1122.
-
Long-term Hepatitis B and Liver Outcomes Among Adults Taking Tenofovir-Containing Antiretroviral Therapy for HBV/HIV Coinfection in Zambia. Clin Infect Dis. 2024 Jun 14; 78(6):1583-1590.
-
Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug Classes. Clin Infect Dis. 2024 Apr 10; 78(4):983-990.
-
A case-control study of risk factors for incident hepatitis B virus infection in South African blood donors. Int J Infect Dis. 2024 Apr; 141:106958.
-
Combined Hepatitis B Virus and Hepatocellular Carcinoma Screening Using Point-of-Care Testing and Ultrasound in a Tanzanian Emergency Department. Am J Trop Med Hyg. 2024 Feb 07; 110(2):399-403.
-
Society for Maternal-Fetal Medicine Consult Series #69: Hepatitis B in pregnancy: updated guidelines. Am J Obstet Gynecol. 2024 04; 230(4):B2-B11.
-
Low frequency of HBsAg reemergence in liver transplant recipients after stopping hepatitis B immune globulin: Implications for prophylaxis protocols. Liver Transpl. 2024 Jun 01; 30(6):668-671.
-
Hepatitis B virus clinical and virologic characteristics in an HIV perinatal transmission study in sub-Saharan Africa. AIDS. 2024 03 01; 38(3):329-337.
-
Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus. Clin Infect Dis. 2023 08 14; 77(3):414-418.